ROSA-BJORKESON DAGMAR

CIK 00016439344 companiesDEERFIELD, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001643934

Recent Transactions

37 trades

Sale
Xencor Inc$XNCR
Common Stock
2024-09-27$20.68/sh−2,503→ 8,490 total
Award
Xencor Inc$XNCR
Stock Option (Right to Buy)
2024-06-13+11,971→ 11,971 total
Award
Xencor Inc$XNCR
Common Stock
2024-06-13+5,986→ 10,993 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−11,625→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−17,719→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,790→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,547→ 0 total
Disposition from Tender
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−14,766→ 0 total
Award
Xencor Inc$XNCR
Common Stock
2023-06-20+5,007→ 5,007 total
Award
Xencor Inc$XNCR
Stock Option (Right to Buy)
2023-06-20+10,013→ 10,013 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-05-24+12,547→ 12,547 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-05-24+8,111→ 26,391 total
Award
Xencor Inc$XNCR
Stock Option (Right to Buy)
2022-06-23+21,412→ 21,412 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2022-05-25+12,790→ 12,790 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2022-05-25+7,737→ 18,280 total
Award
Xencor Inc$XNCR
Stock Option (Right to Buy)
2021-06-24+9,728→ 9,728 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2021-05-27+17,719→ 17,719 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-05-27+10,543→ 10,543 total
Award
Xencor Inc$XNCR
Stock Option (Right to Buy)
2020-06-25+13,953→ 13,953 total
Award
Xencor Inc$XNCR
Stock Option (Right to Buy)
2019-12-18+15,528→ 15,528 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2019-06-01$9.06/sh−246→ 23,431 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2019-04-02$22.80/sh−1,063→ 22,428 total
Award
Keenova Therapeutics plc
Ordinary Shares
2019-04-01+7,638→ 23,491 total
Award
Keenova Therapeutics plc
Employee Share Options (Right to Buy)
2019-04-01+34,953→ 34,953 total
Award
Keenova Therapeutics plc
Employee Share Options (Right to Buy)
2019-04-01+34,953→ 34,953 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2018-06-01$17.05/sh−247→ 15,853 total
Disposition to Issuer
Baxalta Inc
Common Stock, par value $0.01 per share
2016-06-03−71,293→ 0 total
Disposition to Issuer
Baxalta Inc
Stock Option (Right to Buy)
2016-06-03−86,669→ 0 total
Disposition to Issuer
Baxalta Inc
Stock Option (Right to Buy)
2016-06-03−54,553→ 0 total
Award
Baxalta Inc
Common Stock, par value $0.01 per share
2016-03-03+15,259→ 72,119 total
Tax Payment
Baxalta Inc
Common Stock, par value $0.01 per share
2016-03-03$39.30/sh−982→ 71,137 total
Tax Payment
Baxalta Inc
Common Stock, par value $0.01 per share
2015-12-01$34.63/sh−6,893→ 11,610 total
Tax Payment
Baxalta Inc
Common Stock, par value $0.01 per share
2015-12-01$34.63/sh−6,893→ 56,737 total
Other
Baxalta Inc
Common Stock, par value $0.01 per share
2015-07-01+100→ 100 total
Other
Baxalta Inc
Stock Option (Right to Buy)
2015-07-01+86,669→ 86,669 total
Other
Baxalta Inc
Common Stock, par value $0.01 per share
2015-07-01+62,869→ 62,969 total
Other
Baxalta Inc
Stock Option (Right to Buy)
2015-07-01+54,553→ 54,553 total

Companies

Recent Filings

Address

C/O BAXALTA INCORPORATED ONE BAXTER PARKWAY

DEERFIELD, IL, 60015

View on SEC.gov